During the last session, Solid Biosciences Inc (NASDAQ:SLDB)’s traded shares were 0.5 million, with the beta value of the company hitting 2.01. At the end of the trading day, the stock’s price was $4.32, reflecting an intraday loss of -1.14% or -$0.05. The 52-week high for the SLDB share is $15.05, that puts it down -248.38 from that peak though still a striking 33.33% gain since the share price plummeted to a 52-week low of $2.88. The company’s market capitalization is $334.77M, and the average intraday trading volume over the past 10 days was 1.0 million shares, and the average trade volume was 2.42 million shares over the past three months.
Solid Biosciences Inc (SLDB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.08. SLDB has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.54.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Solid Biosciences Inc (SLDB) registered a -1.14% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.14% in intraday trading to $4.32, hitting a weekly high. The stock’s 5-day price performance is -6.09%, and it has moved by -18.95% in 30 days. Based on these gigs, the overall price performance for the year is -68.17%. The short interest in Solid Biosciences Inc (NASDAQ:SLDB) is 7.84 million shares and it means that shorts have 1.39 day(s) to cover.
The consensus price target of analysts on Wall Street is $19, which implies an increase of 77.26% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $12 and $20 respectively. As a result, SLDB is trading at a discount of -362.96% off the target high and -177.78% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 41.25%. While earnings are projected to return 28.29% in 2025, the next five years will return 18.18% per annum.
SLDB Dividends
Solid Biosciences Inc is due to release its next quarterly earnings on 2025-Mar-05. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Solid Biosciences Inc insiders own 0.70% of total outstanding shares while institutional holders control 62.23%, with the float percentage being 62.67%. PERCEPTIVE ADVISORS LLC is the largest shareholder of the company, while 128.0 institutions own stock in it. As of 2024-06-30, the company held over 6.91 million shares (or 16.8725% of all shares), a total value of $39.16 million in shares.
The next largest institutional holding, with 4.33 million shares, is of RA CAPITAL MANAGEMENT, L.P.’s that is approximately 10.579% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $24.55 million.
Also, the Mutual Funds coming in first place with the largest holdings of Solid Biosciences Inc (SLDB) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 854.68 shares. This amounts to just over 1.10 percent of the company’s overall shares, with a $3.69 million market value. The same data shows that the other fund manager holds slightly less at 597.6, or about 0.77% of the stock, which is worth about $2.58 million.
